We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
URG
1301
Ur-Energy
URG
$609M
$24.8K ﹤0.01%
+17,685
New +$29.3K
OCGN icon
1302
Ocugen
OCGN
$465M
$24.6K ﹤0.01%
+15,861
New +$24.7K
PACB icon
1303
Pacific Biosciences
PACB
$482M
$24.1K ﹤0.01%
17,594
+2,249
+15% +$4.54K
FUBO icon
1304
FuboTV Inc
FUBO
$305M
$23.4K ﹤0.01%
1,575
+167
+12% +$2.67K
CIG icon
1305
CEMIG Preferred Shares
CIG
$5.64B
$21.3K ﹤0.01%
+12,112
New +$23.2K
CERS icon
1306
Cerus
CERS
$548M
$20.2K ﹤0.01%
11,460
+1,092
+11% +$1.95K
PL icon
1307
Planet Labs
PL
$7.54B
$18.8K ﹤0.01%
10,108
-349
-3% -$669
FCEL icon
1308
FuelCell Energy
FCEL
$1.54B
$18.6K ﹤0.01%
972
+84
+9% +$2.25K
IAUX
1309
i-80 Gold Corp
IAUX
$1.66B
$16.7K ﹤0.01%
15,430
+3,705
+32% +$4.34K
VISN
1310
Vistance Networks Inc
VISN
$2.68B
$15.9K ﹤0.01%
12,918
+596
+5% +$709
EAF icon
1311
GrafTech
EAF
$194M
$14.7K ﹤0.01%
1,513
+339
+29% +$5.21K
LYEL icon
1312
Lyell Immunopharma
LYEL
$358M
$14.6K ﹤0.01%
503
-31
-6% -$1.48K
NKTR icon
1313
Nektar Therapeutics
NKTR
$2.55B
$14.2K ﹤0.01%
+764
New +$16.1K
AKBA icon
1314
Akebia Therapeutics
AKBA
$260M
$14K ﹤0.01%
+13,701
New +$16.9K
MVIS icon
1315
Microvision
MVIS
$57.5M
$13.6K ﹤0.01%
856
+105
+14% +$2.07K
BLUE
1316
DELISTED
bluebird bio
BLUE
$11.7K ﹤0.01%
592
– –
AAP icon
1317
Advance Auto Parts
AAP
$2.63B
– –
-2,829
Closed -$241K
AGEN
1318
Agenus
AGEN
$352M
– –
-1,151
Closed -$13.3K
AGO icon
1319
Assured Guaranty
AGO
$3.34B
– –
-2,816
Closed -$246K
ALRM icon
1320
Alarm.com
ALRM
$2.83B
– –
-2,914
Closed -$211K
AMBP icon
1321
Ardagh Metal Packaging
AMBP
$3.09B
– –
-19,000
Closed -$65.2K
AMWL icon
1322
American Well
AMWL
$200M
– –
-760
Closed -$12.3K
ARCB icon
1323
ArcBest
ARCB
$3.11B
– –
-1,447
Closed -$206K
BANC icon
1324
Banc of California
BANC
$2.97B
– –
-22,855
Closed -$348K
BF.A icon
1325
Brown-Forman Class A
BF.A
$12.7B
– –
-5,155
Closed -$273K
51 52
53
54 55

Similar funds

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.